HomeCompareMDXHF vs CL

MDXHF vs CL: Dividend Comparison 2026

MDXHF yields 4545.45% · CL yields 2.43%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MDXHF wins by $24684467220188.13M in total portfolio value
10 years
MDXHF
MDXHF
● Live price
4545.45%
Share price
$0.04
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24684467220188.17M
Annual income
$23,660,503,792,881,107,000.00
Full MDXHF calculator →
CL
CL
● Live price
2.43%
Share price
$85.73
Annual div
$2.08
5Y div CAGR
28.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40.8K
Annual income
$5,401.96
Full CL calculator →

Portfolio growth — MDXHF vs CL

📍 MDXHF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMDXHFCL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MDXHF + CL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MDXHF pays
CL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MDXHF
Annual income on $10K today (after 15% tax)
$386,363.64/yr
After 10yr DRIP, annual income (after tax)
$20,111,428,223,948,940,000.00/yr
CL
Annual income on $10K today (after 15% tax)
$206.23/yr
After 10yr DRIP, annual income (after tax)
$4,591.67/yr
At 15% tax rate, MDXHF beats the other by $20,111,428,223,948,935,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MDXHF + CL for your $10,000?

MDXHF: 50%CL: 50%
100% CL50/50100% MDXHF
Portfolio after 10yr
$12342233610094.11M
Annual income
$11,830,251,896,440,556,000.00/yr
Blended yield
95.85%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CL right now

MDXHF
No analyst data
Altman Z
-81.2
Piotroski
3/9
CL
Analyst Ratings
17
Buy
24
Hold
2
Sell
Consensus: Hold
Price Target
$92.45
+7.8% upside vs current
Range: $85.00 — $100.00
Altman Z
4.5
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MDXHF buys
0
CL buys
0
No recent congressional trades found for MDXHF or CL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMDXHFCL
Forward yield4545.45%2.43%
Annual dividend / share$2.00$2.08
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28.6%
Portfolio after 10y$24684467220188.17M$40.8K
Annual income after 10y$23,660,503,792,881,107,000.00$5,401.96
Total dividends collected$24614959662391.29M$18.0K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: MDXHF vs CL ($10,000, DRIP)

YearMDXHF PortfolioMDXHF Income/yrCL PortfolioCL Income/yrGap
1← crossover$465,245$454,545.45$11,012$312.01+$454.2KMDXHF
2$20,261,851$19,764,038.00$12,196$412.95+$20.25MMDXHF
3$826,111,319$804,431,138.78$13,599$549.66+$826.10MMDXHF
4$31,536,344,373$30,652,405,261.22$15,288$736.64+$31536.33MMDXHF
5$1,127,331,439,718$1,093,587,551,239.73$17,353$995.28+$1127331.42MMDXHF
6$37,741,323,559,434$36,535,078,918,935.74$19,926$1,357.80+$37741323.54MMDXHF
7$1,183,503,101,225,504$1,143,119,885,016,909.50$23,194$1,873.82+$1183503101.20MMDXHF
8$34,767,541,536,847,464$33,501,193,218,536,172.00$27,439$2,621.52+$34767541536.82MMDXHF
9$956,975,165,707,534,300$919,773,896,263,107,700.00$33,088$3,727.38+$956975165707.50MMDXHF
10$24,684,467,220,188,170,000$23,660,503,792,881,107,000.00$40,806$5,401.96+$24684467220188.13MMDXHF

MDXHF vs CL: Complete Analysis 2026

MDXHFStock

MedX Health Corp, a medical device and software company, develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, and internationally. The company offers SIAscopy, a medical device technology used to scan skin for suspicious moles and lesions; phototherapeutic medical devices, which use light energy in lower-level laser and LED to provide treatment for pain and tissue damage in the rehabilitation market; and SIAMETRICS, SIMSYS, and MoleMate, which creates real-time images for physicians and dermatologists to evaluate various types of moles or lesions within seconds. It operates DermSecure telemedicine platform that enables the web-based operation of its SIAscopy scanning technology and allows the company to deploy its technology in networks of third-party locations from which patients' mole and lesion images along with other relevant patient information can be connected to specialist physicians for remote assessment. The company was incorporated in 1999 and is headquartered in Mississauga, Canada.

Full MDXHF Calculator →

CLConsumer Staples

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

Full CL Calculator →
📬

Get this MDXHF vs CL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MDXHF vs SCHDMDXHF vs JEPIMDXHF vs OMDXHF vs KOMDXHF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.